Lung benign neoplasm

Summary

Lung benign neoplasm (MONDO:0002732) is a cancer (an umbrella term covering 5 Mondo subtypes) and 1 clinical trial. A subtype of respiratory system benign neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Umbrella term: 5 Mondo subtypes
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	lung benign neoplasm
Mondo ID	MONDO:0002732
DOID	DOID:3683
NCIT	C4454
UMLS	C0345963
MedGen	83393
Anatomy (UBERON)	UBERON:0002048
Is cancer (heuristic)	yes

Also known as: benign lung neoplasm · benign lung tumor · benign lung tumour · benign neoplasm of lung · benign neoplasm of the lung · benign tumor of lung · benign tumor of the lung · benign tumour of lung · benign tumour of the lung · lung benign neoplasm · tumor of the lung · tumour of the lung

Disease family

This is a subtype of respiratory system benign neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › respiratory system benign neoplasm › lung benign neoplasm

Related subtypes (14): endobronchial lipoma, benign laryngeal neoplasm, paranasal sinus Schneiderian papilloma, benign neoplasm of pleura, benign neoplasm of hypopharynx, benign neoplasm of nasal cavity, benign neoplasm of sphenoidal sinus, benign neoplasm of nasopharynx, benign neoplasm of oropharynx, benign neoplasm of frontal sinus, benign neoplasm of maxillary sinus, benign neoplasm of tonsil, benign neoplasm of ethmoidal sinus, benign neoplasm of trachea

Subtypes (5): hemangioma of lung, lung leiomyoma, lung adenoma, clear cell-sugar-tumor of the lung, lung papilloma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01985113	Not specified	COMPLETED	Correlation Research of Thioredoxin Reductase in Lung Cancer